North Carolina – Drug Discovery Alliances (DDA), a leader in connecting pharmaceutical and biotech companies with top industry contractors, has announced the launch of its new licensing portal. The portal will be available on the DDA website and will allow clients to view programs available for licensing, acquisition, or investment.
The new portal is designed to help clients streamline the licensing process and access relevant information on DDA’s programs. Through the portal, clients can quickly and easily find information on available programs, including drug development, clinical trials, and intellectual property assets. The portal also provides access to DDA’s expert team of professionals who can help clients navigate the licensing process and provide support in negotiations.
“We are excited to launch our new licensing portal, which will provide our clients with a one-stop-shop for accessing our programs and expert team,” said Deborah Minor, Ph.D., founder and CEO of Drug Discovery Alliances. “Our goal is to help our clients navigate the licensing process with ease and efficiency, and we believe that this new portal will be an invaluable tool for achieving that goal.”
The new portal reflects DDA’s commitment to innovation and to providing its clients with the highest level of service. The company has a proven track record of connecting pharmaceutical and biotech companies with top industry contractors, facilitating and speeding up projects, and driving success in the industry.
For more information, please visit the DDA website or contact:
- Drug Discovery Alliances at CPHI Barcelona 2023! - October 6, 2023
- Enhancing Resilience in Pharmaceutical Supply Chains with Drug Discovery Alliances - September 4, 2023
- Igniting Innovation through Supplier Diversity: Collaborate with Drug Discovery Alliances at Chemoutsourcing 2023! - August 14, 2023